Medical Devices Investors & VC Firms in New York

83 firms in this list, with a median first check of $1M. 14 of them lead rounds. Generated from verified public data and updated continuously.

Fund	HQ	Invests	Stage	Check	CRM
OrbiMed 122 people · Leads rounds	New York	US	Pre-Seed–Late Stage	$1M – $75M	+ Add to CRM
Deerfield Management Company 88 people	New York	US	Growth–Late Stage	—	+ Add to CRM
Lerer Hippeau 24 people · Leads rounds	New York	US	Seed–Series B	$1M – $5M	+ Add to CRM
Catalio Capital Management, LP 41 people · Follows rounds	New York	US	Seed–Late Stage	—	+ Add to CRM
Colle Capital Partners 31 people · Leads rounds	New York	US	Pre-Seed–Series A	$500K – $2M	+ Add to CRM
Bain Capital Life Sciences 32 people	Boston	US	Series B–Late Stage	—	+ Add to CRM
Aisling Capital 17 people	New York	US	Seed–Series C	—	+ Add to CRM
Casdin Capital 39 people · Follows rounds	New York	US	Seed–Series C	—	+ Add to CRM
Jeito Capital 34 people	Paris	FR	—	—	+ Add to CRM
Artesian 42 people · Leads rounds	Australia	AU	Pre-Seed–Late Stage	—	+ Add to CRM
ARCHIMED Japan 22 people	Lyon	FR	Growth–Late Stage	$10.8M – $1.1B	+ Add to CRM
Cerity Partners Ventures 13 people · Follows rounds	New York	US	Seed–Late Stage	—	+ Add to CRM
Everywhere Ventures 7 people · Follows rounds	New York	US	Pre-Seed–Seed	$250K	+ Add to CRM
Emles Venture Partners 14 people · Follows rounds	New York	US	Pre-Seed–Seed	—	+ Add to CRM
NYU Innovation Venture Fund 32 people	New York	US	Pre-Seed–Series A	$100K – $500K	+ Add to CRM
The Argentum Group 9 people	New York	US	Growth–Late Stage	—	+ Add to CRM
Digitalis Ventures 18 people · Leads rounds	New York	US	Seed–Late Stage	$100K – $10M	+ Add to CRM
Windham Venture Partners 17 people · Leads rounds	New York	US	Series A	$1M – $5M	+ Add to CRM
Signet Healthcare Partners 13 people · Leads rounds	New York	US	Growth–Late Stage	$10M – $50M	+ Add to CRM
Windham Capital Partners 17 people	New York	US	Series A–Growth	—	+ Add to CRM
Essex Woodlands Healthcare Partners 18 people · Leads rounds	New York	US	Growth–Late Stage	$20M – $80M	+ Add to CRM
Adjuvant Capital 22 people	New York	US	Series A–Late Stage	$10M – $25M	+ Add to CRM
Black Opal Ventures 25 people	New York	US	Seed–Late Stage	—	+ Add to CRM
Oberland Capital 20 people	New York	US	Growth–Late Stage	$50M – $300M	+ Add to CRM